Welcome to the e-CCO Library Archive!

Filter:
P166. Prospective evaluation of faecal tumour pyruvate kinase type M2 (M2-PK) in comparison to calprotectin in IBD patients
Authors:

Y.M. Shastri1, N. Povse1, J. Stein2, 1J.W. Goethe University Hospital, Dept. of Medicine I-ZAFES, Frankfurt am Main, Germany, 2Crohn Colitis Zentrum Rhein-Main, Frankfurt am Main, Germany

P166. The physical fitness of IBD patients is impaired
P166

Upper gastrointestinal involvement in asymptomatic Crohn's disease patients in two countries of emerging disease: Asia and Eastern Europe

Authors:

Z. Szepes*1, K. Farkas1, M. Rutka1, H. Chan2, F. Nagy1, L. Tiszlavicz3, W. Tang2, G. Wong2, R. Tang2, A. Lo2, C. Cheung2, S. Wong2, R. Lui2, S. Ng2, T. Molnar1

1University of Szeged, First Department of Medicine, Szeged, Hungary, 2The Chinese University of Hong Kong, Institue of Digestive Disease, Hong Kong, China, 3University of Szeged, Department of Pathology, Szeged, Hungary

P167.

Prediction of clinical outcome in Crohn's disease by using confocal laser endomicroscopy: a prospective, observational, follow-up study

Authors:

G.E. Tontini1,2, J. Mudter3, M. Vieth4, R. Atreya1, C. Günther1, M. Vecchi2,5, M.F. Neurath1, H. Neumann1, 1University of Erlangen-Nuremberg, Medicine I, Erlangen, Germany, 2IRCCS Policlinico San Donato, Gastroenterology and Digestive Endoscopy Unit, San Donato Milanese, Italy, 3Sana Kliniken Ostholstein, Gastroenterology, Eutin, Germany, 4Klinikum Bayreuth, Institute of Pathology, Bayreuth, Germany, 5University of Milan, Department of Biomedical Sciences for Health, Milan, Italy

P167. Crohn & Bone-study: RCT of risedronate in patients with Crohn's disease and osteopenia [on behalf of the Initiative on Crohn's and Colitis1]
P167. How frequent are conversions of tuberculosis (TBC) screening tests among inflammatory bowel disease (IBD) patients under anti‑TNF treatment?
P167. Proposal of a modified phenotype-based radiological classification: the magnetic resonance Crohn's disease severity index (MR- CSI)
Authors:

R. Sacco1, E. Neri2, R. Scandiffio2, L. Faggioni2, M. Bertini1, A. Romano1, F. Costa3, G. Federici1, G. Parisi1, S. Marchi3, G. Bresci1, C. Bartolozzi2, 1Gastroenterology and Metabolic Diseases, Gastroenterology, Pisa, Italy, 2Pisa University Hospital, Radiology, Pisa, Italy, 3Pisa University Hospital, Gastroenterology, Pisa, Italy

P167

Prolonged Small Intestinal Transit in Crohn's Disease is associated with a history of stricturing and penetrating disease.

Authors:

A.-M. Haase*, L. Schoesler, L. Ambrosius Christensen, J. Agnholt, J.F. Dahlerup, K. Krogh

Aarhus University Hospital, Department of Hepatology and Gastroenterology , Aarhus, Denmark

P168.

Predicting outcome in acute ulcerative colitis: Comparison of the Travis and Ho scores using UK IBD Audit data

Authors:

A.M. Churchhouse1, R.W. Lynch1, A. Protheroe2, I.D. Arnott1, 1NHS Lothian, Gastroenterology, Edinburgh, United Kingdom, 2RCP, CEEU, London, United Kingdom

P168. Long-term outcome of fistulizing Crohn's disease treated with infliximab – a 12 years follow up study
P168. Primary sclerosing cholangitis in the Swiss IBD cohort study: prevalence, patient characteristics, and disease course
Authors:

M. Fraga1, N. Fournier2, E. Safroneeva3, S. Vavricka4, D. Moradpour1, A. Schoepfer1, 1University Hospital Lausanne / CHUV, Gastroenterology and Hepatology, Lausanne, Switzerland, 2University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 3University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 4University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland

P168. The majority of patients with inflammatory bowel disease in clinical remission has mucosal inflammation
P168

Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease

Authors:

M.A. Juel*1, S. Rafaelsen2, T. Nathan3, M. Dam Jensen4, J. Kjeldsen4

1Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark, 2Lillebaelt Hospital Vejle, Department of Radiology, Vejle, Denmark, 3Lillebaelt Hospital Vejle, Department of Internal Medicine, Vejle, Denmark, 4Odense University Hospital, Department of Gastroenterology, Odense, Denmark

P169.

Plasma biomarkers of endothelial dysfunction: monocyte chemoattractant protein 1 (MCP 1) and soluble CD40 ligand (CD40L) in patients with inflammatory bowel diseases

Authors:

D. Cibor, D. Owczarek, A. Ciesla, M. Szczepanek, M. Glowacki, T. Mach, Jagiellonian University Medical College, Cracow, Poland, Gastroenterology, Hepatology and Infectious Diseases, Cracow, Poland

P169. Comparison of Crohn's disease and intestinal tuberculosis by clinical, laboratory, endoscopic, radiologic and histologic parameters
P169. Prevalence of vitamin D deficiency in IBD patients and its correlation with disease activity
Authors:

A. Krajcovicova1, J. Toth1, T. Koller1, Z. Zelinkova1, S. Oravcova1, M. Huorka1, T. Hlavaty1, 1University Hospital Bratislava, Bratislava, Slovakia

P169. Risk of permanent stoma in Crohn's colitis: A comparison study between pre-biological era and biological era
P169

Exhaled volatile organic compound breath analysis in Inflammatory Bowel Disease

Authors:

L. Hicks*1, J. Huang2, S. Kumar2, S. Powles1, T. Orchard1, G.B. Hanna2, H. Williams1

1Imperial College London, Gastroenterology, London, United Kingdom, 2Imperial College London, Surgery and Cancer, London, United Kingdom

P170.

Planar radiolabelled white cell scintigraphy and Technetium-99m-HMPAO labeled leukocyte single photon emission computed tomography (SPECT) for assessing endoscopic remission in ulcerative colitis

Authors:

C. Arajol1, O. Puig Calvo2, F. Rodríguez-Moranta1, L. Rodríguez-Alonso1, A. Ruiz-Cerulla1, T. Lobatón1, A. López-Garcia1, J. Martín-Comín2, J. Guardiola-Capón1, 1Bellvitge University Hospital, Gastroenterology, Barcelona, Spain, 2Bellvitge University Hospital, Nuclear Medicine, Barcelona, Spain

P170. Impaired intestional iron absorption in patients with inflammatory bowel disease correlates with disease activity